GLAXF GlaxoSmithKline PLC

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; and a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Note: This is not a U.S. company, but they cross-list their shares on the U.S. over-the-counter market - see the related symbol LN:GSK.

$19.18    Pink
As of 05/14/2021     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  11/21/2018
Outstanding shares:  5,031,444,276
Average volume:  818
Market cap:   $97,250,702,830
Current dividend yield:  4.28%
CUSIP:    
ISIN:        GB0009252882
Sedol:      B01DHS4
Valuation   (See tab for details)
PE ratio:   17.03
PB ratio:   5.99
PS ratio:   2.13
Return on equity:   35.36%
Net income %:   16.21%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy